Clinical Trial Update: A Trial to Evaluate the Effect of the Proton Pump Inhibitor Esomeprazole on the Single-dose Pharmacokinetics (PK) of Oral TAK-906 in Healthy Adult Participants [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the effect of esomeprazole on the single-dose pharmacokinetics of TAK-906 in healthy adults has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Healthy Volunteers

Drugs mentioned

• Esomeprazole (Esomeprazole)
• TAK-906

Snippet

Sponsor: Millennium Pharmaceuticals, Inc. | Conditions: Healthy Volunteers | Phase 1 | Status: COMPLETED | Results posted: 2020-05-12